Abstract
It is widely accepted that glucagon stimulates GH, ACTH and cortisol release in humans, though the mechanisms underlying these effects are unclear. Aim of the present study was to evaluate the stimulatory effect of intramuscolar (im) and intravenous (iv) glucagon (GLU) administration on ACTH, cortisol (F) and GH release in normal adult subjects and to compare its effect on hypothalamo-pituitary adrenal (HPA) axis with that of hCRH. To this goal, in 6 normal young women (26–32 yrs, 50–58 kg) we studied the ACTH and F responses to either im or iv GLU (1 mg, approximately 0.017 mg/kg in subjects of 54.1 ± 1.6 kg) administration as well as to iv hCRH (2.0 μg/kg) or placebo administration. The GH and glucose variations after GLU administration were also studied. Iv GLU did not modify the spontaneous decrease of ACTH and cortisol levels observed after placebo. Conversely, im GLU elicited clear-cut ACTH and F responses (peak vs baseline, mean ± SEM: 53.0 ± 15.2 vs 19.0 ± 1.5 pg/ml, p < 0.05 and 222.3 ± 23.8 vs 158.3 ± 7.0 μg/l, p < 0.05) which were higher than those recorded after hCRH (28.1 ± 4.6 vs 17.4 ± 3.1 pg/ml, p < 0.02 and 182.7 ± 22.8 vs 114.8 ± 12.3 μg/l p < 0.02), though this difference did not attain statistical significance. Also GH rise was recorded after im but not after iv GLU administration (11.6 ± 3.4 vs 3.3 ± 0.7 μg/l, p < 0.05). Thirty min after both iv and im GLU administration glucose levels showed a similar increase followed by similar decrease. The intramuscular administration of GLU induced negligible side-effects in some subject (mild and transient nausea) which, on the contrary, were clear in all subjects after its intravenous administration (nausea, vomiting, tachicardia). In conclusion, glucagon “per se” is not an ACTH, cortisol and GH secretagogue. After intramuscular administration glucagon is a stimulus of HPA axis at least as effective as hCRH. The mechanisms underlying the ACTH, cortisol and GH responses to im glucagon unlikely include glucose variations or stress.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mitchell ML, Byrne M J, Silver J. Growth-hormone release by glucagon. Lancet 1969;1:289–290.
Cain JP, Williams GH, Dluhy RG. Glucagon stimulation of human growth hormone. J Clin Endocrinol Metab1970;31:222–224.
Wieland RG, Hallberg MC, Zorn EM. Growth hormone response to intramuscular glucagon. J Clin Endocrinol Metab 1973;37:329–330.
Spathis GS, Bloom SR, Jeffcoate WJ, Millar JG, Kurtz A, Pyasena MR, Smith JA, Nabarro JD. Subcutaneous glucagon as a test of the ability of the pituitary to secrete GH and ACTH. Clin Endocrinol 1974;3:175–186.
Rao RH, Spathis GS. Intramuscular glucagon as a provocative stimulus for the assessment of pituitary function: growth hormone and cortisol responses. Metabolism1987;36:658–663.
Mukherjee JJ, de Castro JJ, Kaltsas G, Afshar F, Grossman AB, Wass J A, Besser GM. A comparison of the insulin tolerance/glucagon test with the short ACTH stimulation test in the assessment of the hypothalamo-pituitary-adrenal axis in the early post-operative period after hypophysectomy. Clin Endocrinol 1997;47:51–60.
Orme SM, Price A, Weetman AP, Ross RJ. Comparison of the diagnostic utility of the simplified and standard i.m. glucagon stimulation test. Clin Endocrinol 1998;49:773–778.
Frasier SD. A review of growth hormone stimulation tests in children. Pediatrics 1974;53:929–937.
Roth J, Glick S M, Yalow RS, Berson SA. Hypoglycemia: a potent stimulus to secretion of growth hormone. Science1963;140:987–988.
Ghigo E, Bartolotta E, Imperiale E, Bellone J, Cardinale G, Aimaretti G, Valetto MR, Cherubini V, Maccario M, Cocchi D, Camanni F. Glucagon stimulates GHsecretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity. J Endocrinol Invest 1994;17:849–854.
Arvat E, Maccagno B, Di Vito L, Gottero C, Tapliano M, Ghigo E. ACTH-releasing effect of glucagon in humans. Interaction with hCRH, AVP and Hexarelin. J Endocrinol Invest 1999;22(suppl. 4):24.
Ghigo E, Bartolotta E, Imperiale E, Bellone J, Cardinale G, Aimaretti G, Valetto MR, Cherubini V, Maccario M, Cocchi D, Camanni F. About the effects of glucagon on growth hormone release. Letter to the editor. J Endocrinol Invest 1995;18:397.
Pontiroli AE. About the effects of glucagon on growth hormone release. Letter to the editor. J Endocrinol Metab1995;18:396–397.
Milner R D G, Wright A D. Plasma glucose, non-esterified fatty acid, insulin and growth hormone response to glucagon in the newborn. Clin Sci 1967;32:249–252.
Snodgrass G, Stimmler L. The early rise of plasma growth hormone (HGH) and immunoreactive insulin (IRI) in children following intravenous glucagon. J Clin Endocrinol Metab 1971;34:410–413.
Weber B, Helge H, Quabbe H. Glucagon-induced growth hormone release in children. Acta Endocrinol (Copenh) 1970;65:323–341.
Orth DN. Corticotropin-releasing hormone in humans. Endocr Rev 1992;17:164–191
Lefebre P, Luychx A. Glucagon and energetic substrates. Bull Acad R Med Belg 1974;129:143–145.
Kuschke HJ, Klusmann H, Scholkens B. Studies on the effect of glucagon on the human sympatho-adrenal system. Klin Wochenschr 1966 Nov 15; 44(22):1297–1300.
Muller EE, Nisticò G. Neurotransmitter regulation of the anterior pituitary. In: Muller EE, Nisticò G, eds. Brain Messengers and the Pituitary. San Diego: Academic Press, Inc.,1989;404–537.
Eddy RL, Jones L, Hirsh RM. Effect of exogenous glucagon on pituitary polypeptide hormone release. Metabolism1970;19:904–912.
Goke R, Larsen P J, Mikkelsen J D, Sheikh S P. Distribution of GLP-I bindings sites for GLP-1 (7–36)amide on the posterior lobe of the rat pituitary. Neuroendocrinology1995;62:130–133.
Larsen P J, Tag-Christensen M, Jessop D S. Central administration of glucagon-like-peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology1997;138:4445–4455.
Furuse M, Matsumoto M, Saito N, Sugahara K, Hasegawa S. The central corticotropin-releasing factor and glucagonlike peptide-1 in food intake of the neonatal chick. Eur J Pharmacol 1997;339(2–3):211–214.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arvat, E., Maccagno, B., Ramunni, J. et al. Glucagon Is an ACTH Secretagogue as Effective as hCRH after Intramuscolar Administration while It Is Ineffective When Given Intravenously in Normal Subjects. Pituitary 3, 169–173 (2000). https://doi.org/10.1023/A:1011451710004
Issue Date:
DOI: https://doi.org/10.1023/A:1011451710004